Lattice_grid_med
Powered by LatticeGrid

Search Enter term and hit return. Use '*' for as a wildcard.

Publication Listing for the MeSH term Melanoma. Found 41 abstracts

no pagination
Loo K, Soliman I, Renzetti M, Li T, Wu H, Reddy S, Olszanski AJ, Farma JM. Impact of Sun Exposure and Tanning Patterns on Next-Generation Sequencing Mutations in Melanoma. J Surg Res. 2020 May 20;254:147-53.
Uribe-Alvarez C, Guerrero-Rodriguez SL, Rhodes J, Cannon A, Chernoff J, Araiza-Olivera D. Targeting effector pathways in RAC1(P29S)-driven malignant melanoma. Small GTPases. 2020 Feb 17;:1-9.
Webster MR, Fane ME, Alicea GM, Basu S, Kossenkov AV, Marino GE, Douglass SM, Kaur A, Ecker BL, Gnanapradeepan K, Ndoye A, Kugel C, Valiga A, Palmer J, Liu Q, Xu X, Morris J, Yin X, Wu H, Xu W, Zheng C, Karakousis GC, Amaravadi RK, Mitchell TC, Almeida FV, Xiao M, Rebecca VW, Wang YJ, Schuchter LM, Herlyn M, Murphy ME, Weeraratna AT. Paradoxical Role for Wild-Type p53 in Driving Therapy Resistance in Melanoma. Molecular cell. 2020 Feb 06;77(3):633-644e5.
Gibney GT, Hamid O, Lutzky J, Olszanski AJ, Mitchell TC, Gajewski TF, Chmielowski B, Hanks BA, Zhao Y, Newton RC, Maleski J, Leopold L, Weber JS. Phase 1/2 study of epacadostat in combination with ipilimumab in patients with unresectable or metastatic melanoma. Journal for immunotherapy of cancer. 2019 Mar 20;7(1):80.   PMCID: PMC6425606
Ablain J, Xu M, Rothschild H, Jordan RC, Mito JK, Daniels BH, Bell CF, Joseph NM, Wu H, Bastian BC, Zon LI, Yeh I. Human tumor genomics and zebrafish modeling identify SPRED1 loss as a driver of mucosal melanoma. Science (New York, NY). 2018 Nov 30;362(6418):1055-60.   PMCID: PMC6475924
Manley C, Olszanski A. Melanoma in the Bronchus. The New England journal of medicine. 2018 Nov 15;379(20):e36.
Faries MB, Thompson JF, Cochran AJ, Andtbacka RH, Mozzillo N, Zager JS, Jahkola T, Bowles TL, Testori A, Beitsch PD, Hoekstra HJ, Moncrieff M, Ingvar C, Wouters M, Sabel MS, Levine EA, Agnese D, Henderson M, Dummer R, Rossi CR, Neves RI, Trocha SD, Wright F, Byrd DR, Matter M, Hsueh E, MacKenzie-Ross A, Johnson DB, Terheyden P, Berger AC, Huston TL, Wayne JD, Smithers BM, Neuman HB, Schneebaum S, Gershenwald JE, Ariyan CE, Desai DC, Jacobs L, McMasters KM, Gesierich A, Hersey P, Bines SD, Kane JM, Barth RJ, McKinnon G, Farma JM, Schultz E, Vidal-Sicart S, Hoefer RA, Lewis JM, Scheri R, Kelley MC, Nieweg OE, Noyes RD, Hoon DS, Wang HJ, Elashoff DA, Elashoff RM. Completion Dissection or Observation for Sentinel-Node Metastasis in Melanoma. The New England journal of medicine. 2017 Jun 08;376(23):2211-22.   PMCID: PMC5548388
Lu H, Liu S, Zhang G, Bin W, Zhu Y, Frederick DT, Hu Y, Zhong W, Randell S, Sadek N, Zhang W, Chen G, Cheng C, Zeng J, Wu LW, Zhang J, Liu X, Xu W, Krepler C, Sproesser K, Xiao M, Miao B, Liu J, Song CD, Liu JY, Karakousis GC, Schuchter LM, Lu Y, Mills G, Cong Y, Chernoff J, Guo J, Boland GM, Sullivan RJ, Wei Z, Field J, Amaravadi RK, Flaherty KT, Herlyn M, Xu X, Guo W. PAK signalling drives acquired drug resistance to MAPK inhibitors in BRAF-mutant melanomas. Nature. 2017 Oct 05;550(7674):133-6.   PMCID: PMC5891348
Ndoye A, Budina-Kolomets A, Kugel CH, Webster MR, Kaur A, Behera R, Rebecca VW, Li L, Brafford PA, Liu Q, Gopal YN, Davies MA, Mills GB, Xu X, Wu H, Herlyn M, Nicastri MC, Winkler JD, Soengas MS, Amaravadi RK, Murphy ME, Weeraratna AT. ATG5 Mediates a Positive Feedback Loop between Wnt Signaling and Autophagy in Melanoma. Cancer Res. 2017 Nov;77(21):5873-85.   PMCID: PMC5718045
Ribas A, Dummer R, Puzanov I, VanderWalde A, Andtbacka RH, Michielin O, Olszanski AJ, Malvehy J, Cebon J, Fernandez E, Kirkwood JM, Gajewski TF, Chen L, Gorski KS, Anderson AA, Diede SJ, Lassman ME, Gansert J, Hodi FS, Long GV. Oncolytic Virotherapy Promotes Intratumoral T Cell Infiltration and Improves Anti-PD-1 Immunotherapy. Cell. 2017 Sep 07;170(6):1109-1119e10.
Sznol M, Postow MA, Davies MJ, Pavlick AC, Plimack ER, Shaheen M, Veloski C, Robert C. Endocrine-related adverse events associated with immune checkpoint blockade and expert insights on their management. Cancer Treat Rev. 2017 Jul;58:70-6.
Sznol M, Postow MA, Davies MJ, Pavlick AC, Plimack ER, Shaheen M, Veloski C, Robert C. Endocrine-related adverse events associated with immune checkpoint blockade and expert insights on their management. Cancer Treat Rev. 2017 Jul;58:70-6.   PMCID: Review
Zendejas B, Jakub JW, Terando AM, Sarnaik A, Ariyan CE, Faries MB, Zani S, Neuman HB, Wasif N, Farma JM, Averbook BJ, Bilimoria KY, Tyler D, Brady MS, Farley DR. Laparoscopic skill assessment of practicing surgeons prior to enrollment in a surgical trial of a new laparoscopic procedure. Surgical endoscopy. 2017 Aug;31(8):3313-9.   PMCID: PMC6201269
Zendejas B, Jakub JW, Terando AM, Sarnaik A, Ariyan CE, Faries MB, Zani S, Neuman HB, Wasif N, Farma JM, Averbook BJ, Bilimoria KY, Tyler D, Brady MS, Farley DR. Laparoscopic skill assessment of practicing surgeons prior to enrollment in a surgical trial of a new laparoscopic procedure. Surgical endoscopy. 2017 Aug;31(8):3313-9.
Coit DG, Thompson JA, Algazi A, Andtbacka R, Bichakjian CK, Carson WE, Daniels GA, DiMaio D, Ernstoff M, Fields RC, Fleming MD, Gonzalez R, Guild V, Halpern AC, Hodi FS, Joseph RW, Lange JR, Martini MC, Materin MA, Olszanski AJ, Ross MI, Salama AK, Skitzki J, Sosman J, Swetter SM, Tanabe KK, Torres-Roca JF, Trisal V, Urist MM, McMillian N, Engh A. Melanoma, version 2.2016 clinical practice guidelines in oncology. JNCCN Journal of the National Comprehensive Cancer Network. 2016 Apr;14(4):450-73.
Czyz M, Toma M, Gajos-Michniewicz A, Majchrzak K, Hoser G, Szemraj J, Nieborowska-Skorska M, Cheng P, Gritsyuk D, Levesque M, Dummer R, Sliwinski T, Skorski T. PARP1 inhibitor olaparib (Lynparza) exerts synthetic lethal effect against ligase 4-deficient melanomas. Oncotarget. 2016 Nov 15;7(46):75551-60.   PMCID: PMC5342760
Hooper R, Zaidi MR, Soboloff J. The heterogeneity of store-operated calcium entry in melanoma. Science China Life sciences. 2016 Aug;59(8):764-9.   PMCID: PMC4991353
Jakub JW, Terando AM, Sarnaik A, Ariyan CE, Faries MB, Zani S, Neuman HB, Wasif N, Farma JM, Averbook BJ, Bilimoria KY, Allred JB, Suman VJ, Grotz TE, Zendejas B, Wayne JD, Tyler DS. Training High-Volume Melanoma Surgeons to Perform a Novel Minimally Invasive Inguinal Lymphadenectomy: Report of a Prospective Multi-Institutional Trial. Journal of the American College of Surgeons. 2016 Mar;222(3):253-60.   PMCID: PMC5012184
Zibelman M, Pollak N, Olszanski AJ. Autoimmune inner ear disease in a melanoma patient treated with pembrolizumab. Journal for immunotherapy of cancer. 2016 Feb;4:8.   PMCID: PMC4754989
Cheung M, Kadariya Y, Talarchek J, Pei J, Ohar JA, Kayaleh OR, Testa JR. Germline BAP1 mutation in a family with high incidence of multiple primary cancers and a potential gene-environment interaction. Cancer letters. 2015 Dec 28;369(2):261-5.   PMCID: PMC4634709
The above publications are sorted by year, faculty last name, and first author. Click on any highlighted author listed to find all publications attributed to that individual. Click on the publication title to see the abstract. First authors who are faculty are highlighted like this. Last authors who are faculty are highlighted like this. Other authors who are faculty are highlighted like this.

MeSH cloud from publications including the MeSH term Melanoma

Melanoma pathology genetics metabolism melanoma Female Tumor Cell Line drug effects pharmacology Lymph Nodes surgery Signal Transduction methods Neoplasm Drug Resistance antagonists & inhibitors diagnosis adverse effects Ipilimumab Lymph Node Excision Proto-Oncogene Proteins B-raf Mutation Mice Skin Neoplasms therapy diagnostic imaging Protein Kinase Inhibitors Prospective Studies Postoperative Complications Aged Groin dissection education Clinical Competence Neoplasms Programmed Cell Death 1 Receptor enzymology Mitogen-Activated Protein Kinases Monoclonal Antibodies-Humanized Clinical trial beta Catenin Antineoplastic Agents Hypophysitis Laparoscopy Wnt-5a Protein Tumor Microenvironment Assessment drug therapy secondary etiology Videoscopic Male Minimally invasive Nivolumab Thyroiditis Learning curve Neoplastic Gene Expression Regulation Immune-related adverse events Inguinal Lymphatic Metastasis Simulation slow-cycling phenotype Melanocytes Ubiquitin Thiolesterase Enzyme Activation Intention to Treat Analysis Adult Survival Analysis Western Blotting Reproducibility of Results Middle Aged MAP Kinase Signaling System Intracellular Signaling Peptides and Proteins Pak Epacadostat Lymphedema JNK Mitogen-Activated Protein Kinases High-Volume Hospitals DNA Repair Hearing loss PD-1 inhibitor mortality therapy resistance CTLA-4 Antigen Asbestos Piperazines Medical Education-Continuing Proportional Hazards Models Dacarbazine Incidence Animal Disease Models Calcium Young Adult Gene-Environment Interaction Biological Models Histones Sentinel Lymph Node Reverse Transcriptase Polymerase Chain Reaction Autophagy synthetic lethality Cancer predisposition aged microenvironment PARP1 inhibitor oncolytic viruses Experimental Melanoma Feasibility Studies Phosphorylation TOR Serine-Threonine Kinases Endoplasmic Reticulum Phthalazines Sulfonamides Double-Stranded DNA Breaks Immune-related adverse events (irAEs) Prognosis talimogene laherparepvec mrtf Bronchi Learning Curve United States Aminoquinolines tumor microenvironment Sun exposure Watchful Waiting Herpesviridae chemically induced wild-type 53 CD274 Antigens physiology Autoimmune inner ear disease (AIED) Germ-Line Mutation Tumor Suppressor Proteins Bronchial Neoplasms Familial cancer tumor Membrane Proteins Physiological Feedback Groin Srf Immunotherapy Molecular Targeted Therapy Calcium Signaling ORAI1 Protein metastasis interferon gamma Drug Synergism cytotixic deficiency Stromal Interaction Molecule 1 Synthetic Lethal Mutations chemistry Operative Time Endocrine System Diseases
Last updated on Monday, July 06, 2020